CSF2 and neoplasm: While IL-12 monotherapy only induced antitumoral NK cells, the addition of intratumoral GM-CSF succeeded in recruiting activated CD8+ T cells, NKT cells, and macrophages and achieved a higher rate of tumor regressions (see also IL-12) (75).